Maui Derm Hawaii 2026 Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results